When was Lightcast founded?

Lightcast was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is Lightcast located?

Lightcast is headquartered in Cambridge, United Kingdom.

Which legal entities is Lightcast associated with?

Lightcast is associated with Lightcast Discovery Ltd.

How many employees does Lightcast have?

As of Jul 31, 2026, the latest employee count at Lightcast is 96.

Is Lightcast a funded company?

Lightcast is a funded company, having raised a total of $134M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 21, 2019.

How much is Lightcast worth?

The latest valuation of Lightcast is £***** as of Jan 29, 2024.

When was the latest funding round of Lightcast?

Lightcast's latest funding was a $***** Series B round on Apr 15, 2026, with participation from 6 investors.

What is the annual revenue of Lightcast?

Annual revenue of Lightcast is less than £1M as on Dec 31, 2024

Where does Lightcast rank among its competitors?

Lightcast ranks 2nd amongst 24 active competitors, of which 10 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Proteins.1, which secured $4.7M in Apr, 2026.

Who are the top competitors of Lightcast?

Lightcast's top competitors include Mission Bio, Orflo and Singleron. Among them, Proteins.1 secured the most recent funding round in April, 2026.

Lightcast - 2026 Company Profile, Team, Funding, Competitors & Financials

Lightcast is a series B company based in Cambridge (United Kingdom), founded in 2019 by Cameron Frayling. It operates as a Developer of single-cell functional analysis using a droplet-based platform. Lightcast has raised $134M in funding from Arch Venture Partners and M Ventures, with a current valuation of £*****. The company has 24 active competitors, including 10 funded and 1 that has exited. Its top competitors include companies like Mission Bio, Orflo and Singleron.

Company Details

Developer of single-cell functional analysis using a droplet-based platform. The technology uses light rays to precisely control picoliter-scale droplets, enabling scalable assays for drug discovery, therapeutics, and basic research. The system facilitates sequential assays and the real-time dispensing of cells for downstream applications. It supports research into biomolecule secretion, cell-cell communication, and targeted cell killing mechanisms. The platform allows for the precise control of droplet merging to characterize individual cell responses.

Website: www.lightcast.bio/
Social
Email ID: *****@lightcast.bio
Phone Number: +44 **********

Key Metrics

Founded Year

2019

Location

Cambridge, United Kingdom

Stage

Series B

Total Funding

$134M in 7 rounds

Latest Funding Round

Series B, Apr 15, 2026, $*****

Post Money Valuation

£***** as on Jan 29, 2024

Investors

Arch Venture Partners & 20 more

Ranked

2^nd among 24 active competitors

Annual Revenue

£0 - £1M as on Dec 31, 2024

Employee Count

96 as on Jul 31, 2026

Similar Companies

Mission Bio & 24 more

View Lightcast's full profile

Lightcast is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Lightcast Discovery Ltd CIN: 11830666 , United Kingdom, Active	Feb 14, 2019	£0 - £1M (As on Dec 31, 2024)	117 (As on Dec 31, 2024)

Lightcast has raised a total funding of $134M over 7 rounds. Its first funding round was on Jun 21, 2019. Its latest funding round was a Series B round on Apr 15, 2026 for $*****. 6 investors participated in its latest round. Lightcast has 20 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Lightcast:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 15, 2026	7006563	Series B	6866029	7985808	5021904	3047566
Aug 17, 2023	8291493	Series B	7888281	1882522	5740158	Arch Venture Partners & 4 more
Dec 23, 2022	4050073	Series B	1906338	3129868	8683841	7641133

Access funding benchmarks and valuations. Sign up today!

View details of Lightcast's funding rounds and investors

The founders of Lightcast is Cameron Frayling.

Here are the details of Lightcast's key team members:

Cameron Frayling: Founder of Lightcast.
Contact Info: 1 email address

Lightcast's Board of Directors

Lightcast's board has 9 active members. Paul William Loeffen is part of team and Wouter Roeland Andre Meuleman, Matthew Gerard Winston Frohn, Kevin Hrusovsky, Philip Binns, Matthew Frohn, Christian Daniel Uhrich, Kevin Knopp and Keith Crandell are independent board members.

Here is the list of Lightcast's board of directors:

Name	Type	Representing	Status	Duration
xxxvvbr	Team	-	Current	9y 3m
Wouter Roeland Andre Meuleman	Independent board member	-	Current	5y 5m
uvaqfuo	Independent board member	-	Current	2y 3m
byyqcjp	Independent board member	-	Current	3y 9m
ksqpemz	Independent board member	-	Current	3y 5m
cdsjcma	Independent board member	-	Current	6y 3m
y{ntvqe	Independent board member	-	Current	4y 6m
zwxqnlf	Independent board member	-	Current	3y 1m
tdv{itm	Independent board member	-	Current	3y 9m

View details of Lightcast's Founder profiles and Board Members

Lightcast's employee count trend

Lightcast has 96 employees as of Jul 26. Here is Lightcast's employee count trend over the years:

Uncover Lightcast's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lightcast include Mission Bio, Orflo and Singleron. Here is the list of Top 10 competitors of Lightcast, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Mission Bio 2014, San Francisco (United States), Series C	Provider of single cell multiomics platform for genotypic and phenotypic analysis	$120M	LabCorp, Ally Bridge Group & 29 others	65/100
2nd	Lightcast 2019, Cambridge (United Kingdom), Series B	Developer of single-cell functional analysis using a droplet-based platform	$134M	ND Capital, Illumina Ventures & 19 others	58/100
3rd	Orflo 2003, Ketchum (United States), Acquired	Instrumentation for cell and protein analysis	$4.36M	Broadoak Capital Partners, RCT	50/100
4th	Singleron 2018, Hagen (Germany), Series B	Developer of single-cell multi-omics platform for clinical research and molecular diagnosis	$84.5M	Yuanhe Holdings, Frees Fund & 13 others	49/100
5th	Rebus Biosystems 2006, Santa Clara (United States), Series B	Developer of an imaging system for the analysis of genes in a single cell	$20M	Illumina Ventures, LabGenomics & 7 others	46/100
6th	Zafrens 2021, San Diego (United States), Series A	Provider of single-cell multi-omics analysis platform for researchers	$31M	Prime Movers Lab, FoundersX Ventures & 8 others	42/100
7th	Iota Sciences 2016, Oxford (United Kingdom), Series B	Developer of single-cell isolation and automation solutions for cell biology research	$11.9M	Oxford Science Enterprises, Oxford Innovation Finance ... & 8 others	39/100
8th	Wancheng Gene 2017, Shanghai (China), Series A	Provider of single-cell multi-omics technology for research and industrial-grade production	$15.7M	NLVC, CD Capital & 3 others	37/100
9th	Bruker Cellular Analysis 2011, Emeryville (United States), Funding Raised	Developer of solutions for cellular analysis and functional cell biology	-	Northpond Ventures, HHS	36/100
10th	Proteins.1 Finland, Seed	Developer of enzyme-free molecular detection platforms for protein signal analysis	$4.7M	Lifeline Ventures, Cloudberry Ventures & 2 others	32/100